Poulabi Banerjee Selected Research

omega-Chloroacetophenone (Mace)

1/2020

Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Poulabi Banerjee Research Topics

Disease

7	Homozygous Familial Hypercholesterolemia 03/2024 - 03/2018
6	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 01/2017
3	Hypertriglyceridemia 01/2023 - 01/2019
2	Acute Coronary Syndrome 01/2022 - 01/2020
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2020 - 11/2017
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2017
1	Hyperlipidemias (Hyperlipidemia) 03/2024
1	Hypercholesterolemia 03/2024
1	Inborn Genetic Diseases (Disease, Hereditary) 10/2023
1	Atherosclerosis 10/2023
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2023
1	Pancreatitis 01/2023
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2022
1	Body Weight (Weight, Body) 01/2020
1	Unstable Angina 01/2020
1	Myocardial Infarction 01/2020
1	Genetic Risk Score 01/2020
1	Ischemic Stroke 01/2020
1	Rare Diseases (Rare Disease) 11/2019
1	Injection Site Reaction 11/2017
1	Macular Degeneration (Age-Related Maculopathy) 08/2015

Drug/Important Bio-Agent (IBA)

6	oxidized low density lipoproteinIBA 03/2024 - 01/2017
6	LDL CholesterolIBA 03/2024 - 01/2017
6	evinacumabIBA 03/2024 - 11/2019
6	alirocumabIBA 01/2022 - 11/2017
4	LipidsIBA 10/2023 - 01/2017
4	LDL Receptors (LDL Receptor)IBA 10/2023 - 11/2017
4	Proprotein Convertase 9IBA 01/2022 - 03/2018
3	Lipoproteins (Lipoprotein)IBA 03/2024 - 01/2019
3	Triglycerides (Triacylglycerol)IBA 03/2024 - 01/2019
3	AngiopoietinsIBA 01/2023 - 11/2019
3	Monoclonal AntibodiesIBA 01/2020 - 01/2019
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2020
2	Atorvastatin (Lipitor)FDA Link 01/2022 - 11/2017
2	Angiopoietin-Like Protein 3IBA 01/2021 - 01/2019
1	BMS201038IBA 10/2023
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2023
1	Simvastatin (Zocor)FDA LinkGeneric 01/2022
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2020
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 11/2019
1	ApolipoproteinsIBA 03/2018
1	Ezetimibe (Zetia)FDA Link 11/2017
1	Amyloid beta-PeptidesIBA 08/2015

Therapy/Procedure

3	Therapeutics 10/2023 - 01/2020
1	Blood Component Removal (Apheresis) 10/2023
1	Precision Medicine 01/2020
1	Intravenous Infusions 01/2020